Veracyte, Inc. (FRA:12V)
Germany · Delayed Price · Currency is EUR 35.20
-0.20 (-0.56%)
Last updated: Jan 20, 2026, 8:03 AM CET
Veracyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 495.14 | 445.76 | 361.05 | 296.54 | 219.51 | 117.48 | |
Revenue Growth (YoY) | 16.41% | 23.46% | 21.76% | 35.09% | 86.85% | -2.40% |
Cost of Revenue | 145.54 | 136.07 | 112.9 | 101.58 | 74.4 | 40.37 |
Gross Profit | 349.6 | 309.7 | 248.15 | 194.95 | 145.11 | 77.12 |
Selling, General & Admin | 215.58 | 198.78 | 193.1 | 170.61 | 180.38 | 87.61 |
Research & Development | 69.26 | 69.29 | 57.31 | 40.6 | 29.84 | 17.2 |
Amortization of Goodwill & Intangibles | 13.43 | 14.85 | 20.57 | 21.35 | 15.98 | 5.1 |
Operating Expenses | 298.27 | 282.92 | 270.98 | 232.56 | 226.21 | 109.91 |
Operating Income | 51.33 | 26.78 | -22.83 | -37.61 | -81.09 | -32.8 |
Interest Expense | -0 | -0 | -0.02 | -0.2 | -0.24 | -0.23 |
Interest & Investment Income | 12.04 | 11.15 | 7.34 | 1.97 | 0.14 | 0.59 |
Currency Exchange Gain (Loss) | 1.26 | -2.05 | 0.72 | 0.2 | -1.08 | 0.06 |
Other Non Operating Income (Expenses) | -0.34 | 0.5 | 1.13 | 2.68 | 1.44 | 0.06 |
EBT Excluding Unusual Items | 64.29 | 36.38 | -13.65 | -32.96 | -80.84 | -32.32 |
Merger & Restructuring Charges | -5.1 | -5.1 | - | - | - | - |
Asset Writedown | -23.26 | -3.37 | -68.35 | -3.32 | - | -1.09 |
Other Unusual Items | 1.79 | -2.17 | 5.38 | -0.15 | -0.81 | -1.51 |
Pretax Income | 31.01 | 25.74 | -76.61 | -36.43 | -81.65 | -34.91 |
Income Tax Expense | 0.69 | 1.61 | -2.21 | 0.13 | -6.09 | - |
Net Income | 30.32 | 24.14 | -74.4 | -36.56 | -75.56 | -34.91 |
Net Income to Common | 30.32 | 24.14 | -74.4 | -36.56 | -75.56 | -34.91 |
Shares Outstanding (Basic) | 78 | 76 | 73 | 72 | 68 | 53 |
Shares Outstanding (Diluted) | 80 | 78 | 73 | 72 | 68 | 53 |
Shares Change (YoY) | 6.32% | 7.60% | 1.53% | 5.39% | 27.52% | 15.39% |
EPS (Basic) | 0.39 | 0.32 | -1.02 | -0.51 | -1.11 | -0.66 |
EPS (Diluted) | 0.38 | 0.31 | -1.02 | -0.51 | -1.11 | -0.66 |
Free Cash Flow | 98.21 | 63.81 | 34.26 | -1.01 | -37 | -12.55 |
Free Cash Flow Per Share | 1.23 | 0.82 | 0.47 | -0.01 | -0.55 | -0.24 |
Gross Margin | 70.61% | 69.48% | 68.73% | 65.74% | 66.11% | 65.64% |
Operating Margin | 10.37% | 6.01% | -6.32% | -12.68% | -36.94% | -27.91% |
Profit Margin | 6.12% | 5.42% | -20.61% | -12.33% | -34.42% | -29.71% |
Free Cash Flow Margin | 19.84% | 14.31% | 9.49% | -0.34% | -16.85% | -10.68% |
EBITDA | 73.7 | 50.24 | 4.36 | -11.68 | -61.5 | -24.85 |
EBITDA Margin | 14.88% | 11.27% | 1.21% | -3.94% | -28.02% | -21.15% |
D&A For EBITDA | 22.37 | 23.46 | 27.19 | 25.93 | 19.59 | 7.94 |
EBIT | 51.33 | 26.78 | -22.83 | -37.61 | -81.09 | -32.8 |
EBIT Margin | 10.37% | 6.01% | -6.32% | -12.68% | -36.94% | -27.91% |
Effective Tax Rate | 2.23% | 6.24% | - | - | - | - |
Revenue as Reported | 495.14 | 445.76 | 361.05 | 296.54 | 219.51 | 117.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.